RxDB
ICD-10-CM Codes Browse (Tabular) Diagnostic External Drug Neoplasm

P04.1 – Newborn affected by other maternal medication

Overview

Coding Notes

Removed
Non-billable / Non-specific, not valid for HIPAA-covered transactions

Code First

withdrawal symptoms from maternal use of drugs of addiction, if applicable (P96.1)

Type 1 Excludes

dysmorphism due to warfarin (Q86.2)
fetal hydantoin syndrome (Q86.1)

Tyoe 2 Excludes

maternal anesthesia and analgesia in pregnancy, labor and delivery (P04.0)
maternal use of drugs of addiction (P04.4-)

GEM Conversion to ICD-9 CM

Fs: 10000 – Anti-infectives affecting fetus or newborn via placenta or breast milk
Fs: 10000 – Antimetabolic agents affecting fetus or newborn via placenta or breast milk

Child Codes

Newborn affected by maternal antineoplastic chemotherapy
Newborn affected by maternal cytotoxic drugs
Newborn affected by maternal use of anticonvulsants
Newborn affected by maternal use of opiates
Newborn affected by maternal use of antidepressants
Newborn affected by maternal use of amphetamines
Newborn affected by maternal use of sedative-hypnotics
Newborn affected by other maternal medication
Newborn affected by maternal use of unspecified medication
Newborn affected by maternal use of anxiolytics

Sibling Codes

Newborn affected by maternal anesthesia and analgesia in pregnancy, labor and delivery
Newborn affected by maternal use of tobacco
Newborn affected by maternal use of alcohol
Newborn affected by maternal use of drugs of addiction
Newborn affected by maternal use of nutritional chemical substances
Newborn affected by maternal exposure to environmental chemical substances
Newborn affected by other maternal noxious substances
Newborn affected by maternal noxious substance, unspecified

Parent Sibling Codes

Newborn affected by maternal conditions that may be unrelated to present pregnancy
Newborn affected by maternal complications of pregnancy
Newborn affected by complications of placenta, cord and membranes
Newborn affected by other complications of labor and delivery
Newborn affected by noxious substances transmitted via placenta or breast milk
Disorders of newborn related to slow fetal growth and fetal malnutrition
Disorders of newborn related to short gestation and low birth weight, not elsewhere classified
Disorders of newborn related to long gestation and high birth weight
Abnormal findings on neonatal screening

View in Tabular

Code Title
P00-P96 Certain conditions originating in the perinatal period (P00-P96)
P00-P04 Newborn affected by maternal factors and by complications of pregnancy, labor, and delivery (P00-P04)
P04 Newborn affected by noxious substances transmitted via placenta or breast milk
P04.1 Newborn affected by other maternal medication
Type 1 Excludes
dysmorphism due to warfarin (Q86.2)
fetal hydantoin syndrome (Q86.1)

Type 2 Excludes
maternal anesthesia and analgesia in pregnancy, labor and delivery (P04.0)
maternal use of drugs of addiction (P04.4-)

Code First
withdrawal symptoms from maternal use of drugs of addiction, if applicable (P96.1)

P04.11 Newborn affected by maternal antineoplastic chemotherapy
P04.12 Newborn affected by maternal cytotoxic drugs
P04.13 Newborn affected by maternal use of anticonvulsants
P04.14 Newborn affected by maternal use of opiates
P04.15 Newborn affected by maternal use of antidepressants
P04.16 Newborn affected by maternal use of amphetamines
P04.17 Newborn affected by maternal use of sedative-hypnotics
P04.1A Newborn affected by maternal use of anxiolytics
P04.18 Newborn affected by other maternal medication
P04.19 Newborn affected by maternal use of unspecified medication